These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37081500)

  • 21. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
    PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods.
    Perri M; Guta A; Kaminski N; Bonn M; Kolla G; Bayoumi A; Challacombe L; Touesnard N; Gagnon M; McDougall P; Strike C
    Int J Drug Policy; 2023 Jan; 111():103905. PubMed ID: 36379109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    Drug Alcohol Depend; 2020 Nov; 216():108202. PubMed ID: 32948372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A concept mapping study of service user design of safer supply as an alternative to the illicit drug market.
    Pauly B; McCall J; Cameron F; Stuart H; Hobbs H; Sullivan G; Ranger C; Urbanoski K
    Int J Drug Policy; 2022 Dec; 110():103849. PubMed ID: 36215793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada.
    Young S; Kolla G; McCormack D; Campbell T; Leece P; Strike C; Srivastava A; Antoniou T; Bayoumi AM; Gomes T
    Int J Drug Policy; 2022 Apr; 102():103601. PubMed ID: 35124413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
    Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
    Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.
    Lew B; Bodkin C; Lennox R; O'Shea T; Wiwcharuk G; Turner S
    Harm Reduct J; 2022 Mar; 19(1):29. PubMed ID: 35313903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable opioid agonist treatment: An evolutionary concept analysis.
    Haines M; O'Byrne P
    Res Nurs Health; 2021 Aug; 44(4):664-671. PubMed ID: 33993526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.
    Leece P; Khorasheh T; Paul N; Keller-Olaman S; Massarella S; Caldwell J; Parkinson M; Strike C; Taha S; Penney G; Henderson R; Manson H
    BMJ Open; 2019 Sep; 9(9):e028583. PubMed ID: 31515417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces.
    Morris H; Bwala H; Wesley J; Hyshka E
    Can J Public Health; 2023 Jun; 114(3):484-492. PubMed ID: 36689127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.